Plain-English translation of NCT06856850 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for biological markers—measurable signs in the body that can help diagnose and track ALS and frontotemporal dementia. Instead of only studying spinal fluid (which requires a procedure), this study will examine easier-to-collect samples like skin, tears, blood, and tissue from the nose to find new clues about how these diseases develop and progress.
Currently, doctors lack reliable biological markers to quickly and accurately diagnose ALS and frontotemporal dementia, predict who might develop both conditions together, or measure whether treatments are working. This study aims to discover new markers using tissues that haven't been thoroughly studied before, which could transform how these diseases are diagnosed and treated.
You will donate biological samples including skin, tears, blood, and possibly tissue from inside your nose. Researchers may also review your medical records and existing samples. The study is currently enrolling participants, and the first year will focus on collecting these samples from people with ALS, frontotemporal dementia, and people without these conditions for comparison. Samples will be analyzed in the laboratory to search for new biological markers.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
Italy